Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Barclays Plc ADR (BCS)

Barclays Plc ADR (BCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 81,834,472
  • Shares Outstanding, K 3,448,566
  • Annual Sales, $ 38,427 M
  • Annual Income, $ 9,458 M
  • EBIT $ 12,108 M
  • EBITDA $ 14,450 M
  • 60-Month Beta 0.97
  • Price/Sales 2.10
  • Price/Cash Flow 7.74
  • Price/Book 0.79
  • Price/Earnings ttm 10.22
  • Earnings Per Share ttm 2.29
  • Most Recent Earnings $0.46 on 02/10/26
  • Next Earnings Date 04/28/26 [BMO]
  • Annual Dividend & Yield (Fwd) 0.58 (2.47%)
  • Most Recent Dividend 0.289 on 02/20/26
  • Sector Finance
  • INDUSTRY GROUPING:

    SIC-6029 Commercial Banks, NEC

    Banks - Foreign

Options Overview Details

View History
  • Implied Volatility 41.62% (-0.04%)
  • Historical Volatility 42.01%
  • IV Percentile 85%
  • IV Rank 44.72%
  • IV High 60.42% on 04/16/25
  • IV Low 26.41% on 12/22/25
  • Expected Move (DTE 4) 0.94 (3.99%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 3,107
  • Volume Avg (30-Day) 2,735
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 92,731
  • Open Int (30-Day) 79,440
  • Expected Range 22.53 to 24.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.82
  • Number of Estimates 2
  • High Estimate $0.83
  • Low Estimate $0.82
  • Prior Year $0.65
  • Growth Rate Est. (year over year) +26.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.83 +18.88%
on 03/20/26
24.10 -2.16%
on 04/08/26
+3.11 (+15.19%)
since 03/13/26
3-Month
19.83 +18.88%
on 03/20/26
27.70 -14.87%
on 02/03/26
-2.20 (-8.53%)
since 01/13/26
52-Week
14.15 +66.58%
on 04/14/25
27.70 -14.87%
on 02/03/26
+9.64 (+69.15%)
since 04/11/25

Most Recent Stories

More News
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS

NEW YORK , April 9, 2026 /PRNewswire/ --

BCS : 23.69 (-0.17%)
Here's What to Expect From Caterpillar’s Next Earnings Report

Caterpillar is preparing to report its fiscal first-quarter results shortly, and Wall Street anticipates a solid low-double-digit increase in earnings, signaling continued strength across its end markets....

BCS : 23.69 (-0.17%)
XLI : 171.80 (+0.16%)
$SPX : 6,839.42 (+0.33%)
CAT : 789.25 (-0.18%)
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS

NEW YORK , April 4, 2026 /PRNewswire/ --

BCS : 23.69 (-0.17%)
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation – ADMA

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NYSE: BCS) resulting...

BCS : 23.69 (-0.17%)
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS

NEW YORK , March 30, 2026 /PRNewswire/ --

BCS : 23.69 (-0.17%)
Wells Fargo's Q1 2026 Earnings: What to Expect

Wells Fargo is all set to announce its fiscal first-quarter earnings next month, and analysts project a double-digit profit growth.

XLF : 51.28 (+1.00%)
BCS : 23.69 (-0.17%)
WFC : 85.88 (+0.56%)
$SPX : 6,839.42 (+0.33%)
JEF : 45.66 (-0.22%)
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS

NEW YORK , March 24, 2026 /PRNewswire/ --

BCS : 23.69 (-0.17%)
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS

NEW YORK , March 16, 2026 /PRNewswire/ --

BCS : 23.69 (-0.17%)
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS

NEW YORK , March 10, 2026 /PRNewswire/ --

BCS : 23.69 (-0.17%)
Securities Fraud Investigation Into Barclays PLC (BCS) Announced – Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Barclays PLC (“Barclays” or the “Company”)...

BCS : 23.69 (-0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Barclays PLC is a major global banking and financial services company. With 325 years of expertise in banking, and operating through an international network in many countries and regions in Europe, the U.S., Africa & Asia, the company provides a wide range of financial services to individuals, corporations...

See More

Key Turning Points

3rd Resistance Point 24.14
2nd Resistance Point 24.03
1st Resistance Point 23.88
Last Price 23.69
1st Support Level 23.62
2nd Support Level 23.51
3rd Support Level 23.36

See More

52-Week High 27.70
Last Price 23.69
Fibonacci 61.8% 22.53
Fibonacci 50% 20.93
Fibonacci 38.2% 19.33
52-Week Low 14.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.